Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-naïve Asian patients with chronic hepatitis B: a meta-analysis

@inproceedings{Zhao2011ComparisonOT,
  title={Comparison of the 48-week efficacy between entecavir and adefovir in HBeAg-positive nucleos(t)ide-na{\"i}ve Asian patients with chronic hepatitis B: a meta-analysis},
  author={Pan Zhao and Weiwei Liu and Jun Zhao and Qun Guan},
  booktitle={Virology Journal},
  year={2011}
}
Although entacavir and adefovir were widely used in most Asian countries, there were few conclusions drawn from a meta-analysis for comparing the efficacy between entecavir and adefovir in nucleos(t)ide-naïve Asian patients with chronic hepatitis B (CHB). The aim of this study was to evaluate the 48-week efficacy between the two drugs in HBeAg-positive nucleos(t)ide-naïve Asian CHB patients with the method of Meta analysis, which was generally accepted by the international as the best evidence… CONTINUE READING